may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:.
but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment.. september 2013 (21)...